CAR-T cell potency: from structural elements to vector backbone components.

Marzieh Mazinani1, Fatemeh Rahbarizadeh2,3

  • 1Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14115-111, Tehran, Iran.

Biomarker Research
|September 19, 2022
PubMed
Summary

Chimeric antigen receptor (CAR) T cell therapy engineers T cells to fight cancer, with six FDA-approved products available. This review details CAR structures and factors influencing CAR expression for improved efficacy.